Overview
IDEX Q2 sales rise 7% yr/yr to $865 mln, beating analyst expectations
Adjusted EPS for Q2 exceeds analyst expectations, per LSEG data
Outlook
IDEX revises full-year EPS to $6.30-$6.44 GAAP, $7.85-$7.95 adjusted
Company expects Q3 2025 GAAP EPS of $1.54-$1.61
IDEX sees Q3 organic sales growth of 2%-3%
Company anticipates full-year organic sales growth of 1%
Result Drivers
MOTT ACQUISITION - Sales increase driven by Mott acquisition and positive pricing strategies
VOLUME DELEVERAGE - Gross margin affected by unfavorable mix and volume deleverage, partially offset by productivity improvements
INTEREST EXPENSE - Higher interest expense due to debt from Mott acquisition impacted EPS
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$865.40 mln
$858.70 mln (9 Analysts)
Q2 Adjusted EPS
Beat
$2.07
$1.99 (9 Analysts)
Q2 EPS
$1.74
Q2 Adjusted Net Income
Beat
$156.50 mln
$151 mln (6 Analysts)
Q2 Adjusted EBITDA
Beat
$237.20 mln
$209.90 mln (2 Analysts)
Q2 Adjusted Gross Margin
45.3%
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for IDEX Corp is $215.50, about 14.1% above its July 29 closing price of $185.18
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago
Press Release: ID:nBw2qj4d7a
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)